HARBOUR INVESTMENTS, INC.

Position in BCLI — Brainstorm Cell Therapeutics Inc.

CIK 810121 MADISON, WI

Position in BCLI

as of Jun 30, 2025 · filed Jul 28, 2025 Compact

Position Value

$3,986

+$3,827 QoQ

Shares Held

3,559

+6615.1% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HARBOUR INVESTMENTS, INC. holds $3,690,574 across 135 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	16,451	$641,753
2	REGN	Regeneron Pharmaceuticals, Inc.	636	$396,571
3	VRTX	Vertex Pharmaceuticals Inc / Ma	734	$364,599
4	JAZZ	Jazz Pharmaceuticals plc	1,365	$328,924
5	OMER	Omeros Corp	23,139	$220,051
6	CRSP	CRISPR Therapeutics AG	3,533	$192,689
7	STOK	Stoke Therapeutics, Inc.	4,413	$144,393
8	NTLA	Intellia Therapeutics, Inc.	7,534	$127,475

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-06-30	$3,986	3,559	+347.1%	Shares	Sole	2025-07-28
2023-09-30	$159	796	-46.0%	Shares	Sole	2023-11-15
2023-06-30	$3,038	1,475	0.0%	Shares	Sole	2023-08-15
2023-03-31	$4,867	1,475	-17.2%	Shares	Sole	2023-05-15
2022-12-31	$2,920	1,781	-32.4%	Shares	Sole	2023-02-16
2022-09-30	$11,642	2,634	0.0%	Shares	Sole	2022-11-15
2022-06-30	$7,269	2,634	-40.1%	Shares	Sole	2022-08-15
2021-12-31	$17,596	4,399	-46.8%	Shares	Sole	2022-02-16
2021-09-30	$27,287	8,269	-12.4%	Shares	Sole	2021-11-15
2021-06-30	$35,887	9,444	-0.1%	Shares	Sole	2021-08-16
2021-03-31	$36,212	9,455	—	Shares	Sole	2021-08-17
No filing history on record for this holder in this stock.